Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glucon-D is a widely recognized over-the-counter glucose-based energy supplement powder, primarily marketed in India and South Asia. The formulation consists of high-grade dextrose (glucose) enriched with Vitamin D (typically Vitamin D2/ergocalciferol) and essential minerals, including calcium and phosphorus. It is designed to provide an immediate source of energy and is commonly used to combat dehydration, heat exhaustion, and physical fatigue. The brand was historically owned by Heinz India and was later acquired by Zydus Wellness. In clinical research settings, such as the Aga Khan University trial (NCT02097108) investigating bovine lactoferrin for the prevention of neonatal sepsis, Glucon-D has been utilized as a placebo or control intervention due to its inert nature relative to the active biologic and its widespread availability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Glucon-D.